On Thursday, Conduit Pharmaceuticals Inc (CDT) stock saw a decline, ending the day at $0.1 which represents a decrease of $-0.01 or -9.09% from the prior close of $0.11. The stock opened at $0.11 and ...

We forecast 2025 CMBS (conduit and single borrower ... CMBS delinquency and special servicing rates continued to climb, reaching 6% and 9.1%, respectively, as of October 2024. With the expected dollar ...

In recent trading, Conduit Pharmaceuticals Inc (CDT) stock price has shown some volatility, fluctuating -2.19% over the last five trades and -17.92% over the past 30 trades. This represents a notable ...

The re/insurance market has absorbed the elevated level of small and medium sized catastrophe events around the world so far ...

Bermuda-based reinsurer Conduit Re generated reinsurance revenue of $588.2 million for the first nine months of 2024, an ...

On a call to discuss the carrier’s nine-month results today, CEO Trevor Carvey said Conduit has increased its specialty ...

Atomic Rules LLC, a supplier of enterprise-grade FPGA IP cores and solutions, today shipped Arkville® 24.11, the 28th ...

KBRA releases research analyzing multifamily distress across CMBS conduits and Freddie Mac (FM) securitizations. Multifamily properties are facing slower rent growth, heavy supply, and inflationary ...

Delinquencies of CMBS conduit loan secured by U.S. office properties increased 56 basis points in the last month to reach ...

Conduit Re reported gross premiums written of $957.3 million, marking a 25.2% increase compared to the same period in 2023. Reinsurance revenue reached $588.2 million, reflecting a 30.3% increase. The ...

In the first nine months of the year, the Bermuda-based reinsurance business said gross premiums written grew 25% on-year to USD957.3 million from USD764.4 million. Reinsurance revenue came in 30% ...